K. Link

发表

Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency

D. Russell, D. Nordling, P. Malik, 2016, Molecular therapy. Methods & clinical development.

The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO.

G. Marcucci, S. Shen, K. Link, 2012, Blood.

Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation

C. Bloomfield, Melissa Bowman, K. Link, 2016, Proceedings of the National Academy of Sciences.

AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3

M. Carroll, K. Link, M. Wunderlich, 2010, Leukemia.

Suppression of apoptosis by TP53 mutation contributes to resistance of acute myeloid leukemia (AML) to conventional cytotoxic treatment. Using differentiation to induce irreversible cell cycle exit in AML cells could be a p53-independent treatment alternative, however, this possibility requires eval

J. Maciejewski, A. Advani, R. Mahfouz, 2011 .

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

J. Maciejewski, Y. Saunthararajah, A. Advani, 2011, Leukemia.

Non-p53 Dependent, Leukemia Initiating-Cell Selective, Therapy.

J. Maciejewski, Y. Saunthararajah, A. Advani, 2009 .

Differentiation-Chronology Specific Function of DNMT1 and Selective Anti-Leukemia Stem-Cell Therapy

J. Maciejewski, Y. Saunthararajah, K. Link, 2008 .

Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells.

Masahiro Nakagawa, Gang Huang, Lea Cunningham, 2013, The Journal of clinical investigation.

BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF

B. Weissman, K. Knudsen, C. Burd, 2005, Molecular and Cellular Biology.

Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

F. Claessens, K. Knudsen, C. Comstock, 2008, Cancer research.

BAF57 MODULATION OF ANDROGEN RECEPTOR ACTION AND PROSTATE CANCER PROGRESSION

K. Link, 2008 .

MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.

B. Aronow, K. Link, M. Wunderlich, 2015, Blood.

Core binding factor at the crossroads: Determining the fate of the HSC

K. Link, J. Mulloy, F. Chou, 2010, Journal of cellular physiology.

Differential Requirement of SWI/SNF for Androgen Receptor Activity*

K. Knudsen, K. Link, Christin E Petre-Draviam, 2003, Journal of Biological Chemistry.

OlRIGINAL ARTICLE p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

J. Maciejewski, Y. Saunthararajah, A. Advani, 2011 .

UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO

Salam A. Assi, C. Bloomfield, N. Nassar, 2016, Leukemia.

Transcription factor RUNX 1 promotes survival of acute myeloid leukemia cells

Yue Zhang, H. Grimes, M. Kurokawa, 2013 .

A New Immunodeficient Mouse Strain, NOD/SCID IL2Rγ−/− SGM3, Promotes Enhanced Human Hematopoietic Cell Xenografts with a Robust T Cell Component.

K. Link, M. Wunderlich, J. Mulloy, 2009 .

Genetic Models Demonstrate a Requirement of MEIS1 in Survival of MLL-AF9 Leukemia

K. Link, J. Mulloy, Jayeeta Roychoudhury, 2012 .